Abstract
Fungal diseases are one of the urgent medical and social problems that need to be solved and to seek different methods of treatment. The work demonstrates the use of antimycotic external exposure “Bifonazol”. A successful evaluation of microbiological and clinical studies in 39 patients has been performed. The main pathogens of superficial mycotic skin lesions are characterized by high sensitivity to the drug, manifested with relatively large growth retardation diameters of their cultures (> 25 mm) when tested in vitro. As a result of observation of patients, who used bifonazole, complete clinical and laboratory healing was established for 28 days of treatment in 100% of cases. In turn, the drug has a minimal abortion system, which helps to avoid side effects on the body.
Highlights
Summary
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
